regenerative medicine, stem cell therapy in Mexico, Stem cell therapy in Baja California,

TreVita Expands Donor-Derived Stem Cell Therapy in Mexico

TreVita Announces Its Expansion In Regenerative Medicine

Regenerative medicine is becoming an increasingly important part of the medical travel conversation, and TreVita is expanding its offerings in response.

TreVita announced the expansion of its regenerative medicine program in Baja California, Mexico. The announcement highlights a broader focus on individualized care, cellular quality, transparency, and the patient experience.

individualized care
cellular quality
transparency
the patient experience
01 / The Program

A Broader Regenerative Medicine Program

TreVita is broadening its existing stem cell services across additional areas of regenerative medicine.

The announcement specifically highlights:

Healthy aging & rejuvenation
Sports & orthopedic injuries
Additional regenerative medicine applications

TreVita's regenerative medicine program emphasizes individualized physician evaluation rather than predetermined treatment packages.

The process starts with the individual, not a predetermined treatment.

Physicians evaluate a client's medical history, current condition, diagnostic information, and treatment goals before determining whether the client may be an appropriate candidate and what approach, if any, should be considered.

01
Medical history
02
Current condition
03
Diagnostic information
04
Treatment goals

The expansion reflects TreVita's growing focus on regenerative medicine as part of its broader medical travel platform.

Want to know what's behind the expansion?

Read the full announcement
02 / The Experience

A More Individualized Experience

One of the key themes in the announcement is that regenerative medicine should not be approached as a one-size-fits-all experience.

TreVita's expanded program centers on individualized physician evaluation and treatment planning, with the goal of helping clients better understand their options before moving forward.

The announcement also puts a strong emphasis on transparency around the cellular products clients receive. This includes information such as the cell type and source, cell count, viability, delivery method, testing, and documentation, along with the physician's rationale for the treatment plan.

Transparency around the cellular products
✓
Cell type and source
✓
Cell count
✓
Viability
✓
Delivery method
✓
Testing
✓
Documentation
✓
The physician's rationale for the treatment plan

For patients considering regenerative medicine, knowing that a treatment involves stem cells is only part of the picture.

Understanding what is being provided, and having clear information about it, is an important part of making an informed decision.
03 / What's Next

Where TreVita Is Going Next

The announcement offers a look at where TreVita is taking its regenerative medicine program and its broader vision for medical travel.

Rather than focusing only on getting patients from one location to another, TreVita describes a model that connects physicians, science, cellular products, and the patient experience.

Physicians
Science
Cellular products
The patient experience

It's a look at how the company is building the next stage of its regenerative medicine offering.

Read the Full Press Release
Get in touch

Start with your questions. We'll help you find the answers.